Kairos Pharma Ltd (KAPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KAPA | AZN | AMGN | GILD | BMY |
| Company | Kairos Pharma Ltd | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.4700 | 186.69 | 336.26 | 133.77 | 56.69 |
| High | 0.5100 | 186.70 | 337.94 | 134.65 | 57.04 |
| Low | 0.4500 | 184.70 | 333.47 | 131.81 | 56.10 |
| Latest | 0.4900 | 184.96 | 336.23 | 132.06 | 56.77 |
| Change | +0.0260 | -2.76 | -0.22 | -0.99 | +0.38 |
| % Change | +5.60% | -1.47% | -0.07% | -0.74% | +0.67% |
| Volume | 212,512 | 1,027,725 | 2,040,326 | 4,532,214 | 7,686,457 |
| 20-Day Average Volume | 155,916 | 2,065,166 | 2,693,551 | 6,265,516 | 10,186,958 |
| Previous Close | 0.4640 | 187.72 | 336.45 | 133.05 | 56.39 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5747 | 188.18 | 338.36 | 132.68 | 57.81 |
| 20-Day Raw Stochastic | 21.43% | 19.60% | 43.18% | 36.47% | 25.40% |
| 20-Day Relative Strength | 37.16 | 43.80 | 45.29 | 44.39 | 45.56 |
| Weighted Alpha | -42.21 | +27.52 | +18.82 | +23.05 | +21.33 |
| Today's Opinion | 100% Sell | 16% Sell | 24% Sell | 8% Sell | 8% Buy |
| Previous Opinion | 100% Sell | 8% Buy | 24% Sell | 24% Buy | 16% Buy |
| Last Month's Opinion | 88% Sell | 88% Buy | 24% Buy | 56% Buy | 48% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.65% since 05/07/26 | +1.34% since 05/07/26 | +2.17% since 05/07/26 | -1.49% since 05/07/26 | +0.92% since 05/07/26 |
| Low | 0.4300 on 05/13/26 | 181.58 on 05/08/26 | 327.62 on 05/11/26 | 129.00 on 05/08/26 | 55.40 on 05/11/26 |
| High | 0.5700 on 05/08/26 | 187.78 on 05/13/26 | 338.49 on 05/12/26 | 137.50 on 05/12/26 | 57.04 on 05/14/26 |
| 1-Month | |||||
| %Chg | -18.27% since 04/14/26 | -9.50% since 04/14/26 | -4.19% since 04/14/26 | -5.97% since 04/14/26 | -2.26% since 04/14/26 |
| Low | 0.4300 on 05/13/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.7100 on 04/22/26 | 205.30 on 04/17/26 | 356.90 on 04/20/26 | 140.96 on 04/15/26 | 60.78 on 04/30/26 |
| 3-Month | |||||
| %Chg | -18.06% since 02/13/26 | -10.02% since 02/13/26 | -8.93% since 02/13/26 | -14.79% since 02/13/26 | -6.54% since 02/13/26 |
| Low | 0.4300 on 05/13/26 | 180.00 on 05/05/26 | 320.52 on 05/05/26 | 127.64 on 04/27/26 | 55.40 on 05/11/26 |
| High | 0.7500 on 02/26/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -40.92% since 11/14/25 | +3.79% since 11/14/25 | -0.15% since 11/14/25 | +5.63% since 11/14/25 | +21.69% since 11/14/25 |
| Low | 0.4300 on 05/13/26 | 176.82 on 11/20/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 1.0400 on 01/08/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 9,935 | 291,136,448 | 181,577,024 | 165,190,896 | 115,152,384 |
| Shares Outstanding, K | 21,411 | 1,550,908 | 539,685 | 1,241,570 | 2,042,071 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -5,450,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Quarter Net Income | -1,370,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 1.51 | 0.26 | 0.44 | 0.31 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.07 on 03/31/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 1.58 on 04/30/26 |
| Earnings Date | 05/13/26 | 08/04/26 | 08/04/26 | 08/06/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 19.93 | 15.22 | 16.12 | 9.52 |